PUTRAJAYA, Oct 23 (Bernama) -- The 13-valent pneumococcal conjugate vaccine (PCV13) plays an important role in preventing serious infections caused by the bacterium Streptococcus pneumoniae, particularly among children under five who face a higher risk of complications.
General : PCV13 Helps Protect Children From Serious Pneumococcal Disease
pneumococcal, conjugate vaccine, PCV13, pneumonia,
BE Bernama 
Key takeaways
PCV13 protects children under five from serious pneumococcal diseases caused by 13 serotypes of Streptococcus pneumoniae.
- PCV13 prevents infections like pneumonia, meningitis, and bloodstream infections in children.
- Children under five are more vulnerable due to underdeveloped immune systems.
- The vaccine's effectiveness and relevance depend on Malaysia's disease patterns and cost.
Summarised automatically by AI from the original article by Bernama. AI can make mistakes, so check the original for details.
Read the full story on Bernama That's the opening of the story. The full piece is published by Bernama.
Continue reading ↗ Story details
- Published
- Section
- news
- Format
- Article
- Original
- bernama.com ↗
Related reporting
4 stories on this topic from 4 sources, oldest first.
- Free Malaysia Today Unicef calls for stronger measures to protect children from haze
- New Straits Times Asean must unite to protect children from growing online threats - Fahmi
- Bernama General : PCV13 Helps Protect Children From Serious Pneumococcal Disease (this story)
